Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants
Sponsor: University Hospital, Basel, Switzerland
Summary
Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. These acute subjective effects of MDMA may be helpful to assist psychotherapy and MDMA has been investigated in phase 3 trials as a possible treatment in post-traumatic stress disorder.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2025-07-29
Completion Date
2026-11
Last Updated
2025-07-30
Healthy Volunteers
Yes
Conditions
Interventions
R-3,4-methylenedioxymethamphetamine
A dose of 300mg enantiomeric R-MDMA will be administered.
S-3,4-methylenedioxymethamphetamine
A dose of 100mg enantiomeric S-MDMA will be administered.
Placebo
Placebo (Mannitol)
Locations (1)
University Hospital Basel
Basel, Canton of Basel-City, Switzerland